{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:27:33Z","timestamp":1791908853834,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":1852,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/mi.2016.35","type":"journal-article","created":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T11:38:29Z","timestamp":1459942709000},"page":"162-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Sphingosine-1-phosphate receptor-1 (S1P1) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel disease"],"prefix":"10.1016","volume":"10","author":[{"given":"T.","family":"Karuppuchamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E-h","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gonz\u00e1lez-Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sarkisyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Gima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bamias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Jedlicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Veny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Peach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Rivera-Nieves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mi.2016.35_bib1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1038\/mi.2016.35_bib2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn's disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1038\/mi.2016.35_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa020732","article-title":"Natalizumab for active Crohn's disease","volume":"348","author":"Ghosh","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1038\/mi.2016.35_bib4","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(15)30321-8","article-title":"445 The TOUCHSTONE Study: A Randomized, Double-Blind, Placebo-Controlled Induction Trial of an Oral S1P Receptor Modulator (RPC1063) in Moderate to Severe Ulcerative Colitis","volume":"148","author":"Sandborn","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1038\/mi.2016.35_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1083\/jcb.114.1.155","article-title":"Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation","volume":"114","author":"Zhang","year":"1991","journal-title":"J. Cell Biol."},{"key":"10.1038\/mi.2016.35_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/08820130600616490","article-title":"Sphingosine kinase and sphingosine-1-phosphate regulate migration, endocytosis and apoptosis of dendritic cells","volume":"35","author":"Eigenbrod","year":"2006","journal-title":"Immunol. Invest."},{"key":"10.1038\/mi.2016.35_bib7","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1126\/science.1113640","article-title":"Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients","volume":"309","author":"Schwab","year":"2005","journal-title":"Science"},{"key":"10.1038\/mi.2016.35_bib8","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jcb.20127","article-title":"Structural and functional characteristics of S1P receptors","volume":"92","author":"Sanchez","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"10.1038\/mi.2016.35_bib9","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1053\/j.gastro.2008.08.053","article-title":"CD44 deficiency attenuates chronic murine ileitis","volume":"135","author":"Collins","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1038\/mi.2016.35_bib10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.devcel.2012.08.005","article-title":"The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2","volume":"23","author":"Gaengel","year":"2012","journal-title":"Dev. Cell"},{"key":"10.1038\/mi.2016.35_bib11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1073\/pnas.1014154108","article-title":"FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation","volume":"108","author":"Choi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1038\/mi.2016.35_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"key":"10.1038\/mi.2016.35_bib13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ni1542","article-title":"Follicular shuttling of marginal zone B cells facilitates antigen transport","volume":"9","author":"Cinamon","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1038\/mi.2016.35_bib14","doi-asserted-by":"crossref","first-page":"13839","DOI":"10.1074\/jbc.M311743200","article-title":"Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate","volume":"279","author":"Sanna","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1038\/mi.2016.35_bib15","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1182\/blood-2003-02-0460","article-title":"G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation","volume":"102","author":"Allende","year":"2003","journal-title":"Blood"},{"key":"10.1038\/mi.2016.35_bib16","doi-asserted-by":"crossref","first-page":"F1516","DOI":"10.1152\/ajprenal.00311.2005","article-title":"Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney","volume":"290","author":"Awad","year":"2006","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1038\/mi.2016.35_bib17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nchembio.547","article-title":"Actions of a picomolar short-acting S1P(1) agonist in S1P(1)-eGFP knock-in mice","volume":"7","author":"Cahalan","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1038\/mi.2016.35_bib18","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/ibd.21304","article-title":"Homing of immune cells: role in homeostasis and intestinal inflammation","volume":"16","author":"Hart","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1038\/mi.2016.35_bib19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1038\/mi.2016.35_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nri2974","article-title":"The outs and the ins of sphingosine-1-phosphate in immunity","volume":"11","author":"Spiegel","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1038\/mi.2016.35_bib21","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/ni.2745","article-title":"Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells","volume":"14","author":"Skon","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1038\/mi.2016.35_bib22","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.4049\/jimmunol.175.5.2960","article-title":"Sphingosine-1-phosphate mediates migration of mature dendritic cells","volume":"175","author":"Czeloth","year":"2005","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2016.35_bib23","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/intimm\/dxn050","article-title":"Sphingosine-1-phosphate receptor type-1 agonism impairs blood dendritic cell chemotaxis and skin dendritic cell migration to lymph nodes under inflammatory conditions","volume":"20","author":"Gollmann","year":"2008","journal-title":"Int. Immunol."},{"key":"10.1038\/mi.2016.35_bib24","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.4049\/jimmunol.178.6.3437","article-title":"Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3","volume":"178","author":"Maeda","year":"2007","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2016.35_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1074-7613(00)80323-4","article-title":"CD28\/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes","volume":"5","author":"Lenschow","year":"1996","journal-title":"Immunity"},{"key":"10.1038\/mi.2016.35_bib26","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1182\/blood-2001-11-0097","article-title":"Characterization of human blood dendritic cell subsets","volume":"100","author":"MacDonald","year":"2002","journal-title":"Blood"},{"key":"10.1038\/mi.2016.35_bib27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1074-7613(00)80038-2","article-title":"Impaired on\/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies","volume":"10","author":"Kontoyiannis","year":"1999","journal-title":"Immunity"},{"key":"10.1038\/mi.2016.35_bib28","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/gutjnl-2011-300820","article-title":"Flt3 ligand expands CD103+ dendritic cells and FoxP3+ T regulatory cells, and attenuates Crohn's-like murine ileitis","volume":"61","author":"Collins","year":"2012","journal-title":"Gut"},{"key":"10.1038\/mi.2016.35_bib29","doi-asserted-by":"crossref","first-page":"H1791","DOI":"10.1152\/ajpheart.00552.2003","article-title":"The vascular contribution in the pathogenesis of inflammatory bowel disease","volume":"285","author":"Hatoum","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1038\/mi.2016.35_bib30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1194\/jlr.M034108","article-title":"S1P(1) localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity","volume":"54","author":"Montrose","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1038\/mi.2016.35_bib31","first-page":"699","article-title":"The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice","volume":"16","author":"Deguchi","year":"2006","journal-title":"Oncol. Rep."},{"key":"10.1038\/mi.2016.35_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00054725-200405000-00002","article-title":"Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitis","volume":"10","author":"Mizushima","year":"2004","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1038\/mi.2016.35_bib33","doi-asserted-by":"crossref","first-page":"G267","DOI":"10.1152\/ajpgi.00496.2005","article-title":"FTY720 suppresses CD4+CD44highCD62L- effector memory T cell-mediated colitis","volume":"291","author":"Fujii","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1038\/mi.2016.35_bib34","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.4049\/jimmunol.178.4.2458","article-title":"FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells","volume":"178","author":"Daniel","year":"2007","journal-title":"J. Immunol."},{"key":"10.1038\/mi.2016.35_bib35","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s10620-011-1628-8","article-title":"Pharmacologic evaluation of sulfasalazine, FTY720, and anti-IL-12\/23p40 in a TNBS-induced Crohn's disease model","volume":"56","author":"Radi","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"10.1038\/mi.2016.35_bib36","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1096\/fj.08-124891","article-title":"Immunosuppressive human anti-lymphocyte autoantibodies specific for the type 1 sphingosine 1-phosphate receptor","volume":"23","author":"Liao","year":"2009","journal-title":"FASEB J."},{"key":"10.1038\/mi.2016.35_bib37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1124\/jpet.106.119172","article-title":"A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice","volume":"324","author":"Song","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1038\/mi.2016.35_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/gutjnl-2011-301272","article-title":"Ectopic lymphoid tissue alters the chemokine gradient, increases lymphocyte retention and exacerbates murine ileitis","volume":"62","author":"McNamee","year":"2013","journal-title":"Gut"},{"key":"10.1038\/mi.2016.35_bib39","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ibd.21148","article-title":"Novel model of TH2-polarized chronic ileitis: the SAMP1 mouse","volume":"16","author":"McNamee","year":"2010","journal-title":"Inflamm. Bowel. Dis."},{"key":"10.1038\/mi.2016.35_bib40","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1053\/gast.2001.29568","article-title":"Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1\/Yit adoptive transfer model of Crohn's disease in mice","volume":"121","author":"Burns","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1038\/mi.2016.35_bib41","doi-asserted-by":"crossref","first-page":"C1460","DOI":"10.1152\/ajpcell.00382.2011","article-title":"Real-time differential labeling of blood, interstitium, and lymphatic and single-field analysis of vasculature dynamics in vivo","volume":"302","author":"Sarkisyan","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1038\/mi.2016.35_bib42","doi-asserted-by":"crossref","first-page":"C14","DOI":"10.1152\/ajpcell.00043.2014","article-title":"Host endothelial S1PR1 regulation of vascular permeability modulates tumor growth","volume":"307","author":"Sarkisyan","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mi201635.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mi201635","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922006316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922006316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mi201635.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:18:01Z","timestamp":1761830281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021922006316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1933021922006316"],"URL":"https:\/\/doi.org\/10.1038\/mi.2016.35","relation":{},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sphingosine-1-phosphate receptor-1 (S1P1) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mi.2016.35","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 \u00a9 Society for Mucosal Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}